Advertisement

Topics

Companies Related to "Amyotrophic lateral sclerosis Market Insights Epidemiology Market Forecast" [Most Relevant Company Matches] RSS

01:38 EST 22nd February 2019 | BioPortfolio

Here are the most relevant search results for "Amyotrophic lateral sclerosis Market Insights Epidemiology Market Forecast" found in our extensive corporate database of over 50,000 company records.

Showing "Amyotrophic lateral sclerosis Market Insights Epidemiology Market Forecast" Companies 1–25 of 4,500+

Extremely Relevant

SOLOMON PARK RESEARCH INSTITUTE

Solomon Park Research Institute is a non-profit foundation specializing in neurobiological research. The institute was founded and incorporated in 1985. Initial funding for the Institute was provided by the Amyotrophic Lateral Sclerosis Society of America (ALSSOA) and subsequent research has focused largely on this disease. The Institute has also received a grant from the Amyotrophic Lateral Scl...


Maas Biolab, LLC

Maas Biolab is a private pharmaceutical company in Albuquerque, New Mexico, USA, developing Mitogard®, the only cyclosporin formula designed for CSF delivery, to treat amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. (http://www.maasbiolab.com)

Amorfix Life Sciences Ltd.

The Aggregated Misfolded Protein diseases include Transmissible Spongiform Encephalopathies (TSE), such as Bovine Spongiform Encephalopathy (BSE) and the human form variant Creutzfeldt-Jakob Disease (vCJD), as well as degenerative diseases such as Alzheimer's Disease (AD), Amyotrophic Lateral Sclerosis (ALS) and Parkinson's Disease (PD).


Premier Biomedical, Inc.

Premier Biomedical, Inc. is a research-based company that intends to discover and develop medical treatments for humans, specifically targeting the treatment of Alzheimer's Disease, Fibromyalgia, Multiple Sclerosis, Traumatic Brain Injury, Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig's Disease), Blood Sepsis and Viremia, and Cancer. Premier has licensed t...

Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Relevant

Axaron Bioscience AG

Axaron Bioscience AG is a biotech company that aims to develop drugs which address the large-volume and fast growing neurodegenerative disorders market. The company has built an attractive portfolio of compounds focused on the treatment of stroke, Spinal Cord Injury (SCI), ALS (Amyotrophic Lateral Sclerosis) and Parkinson's disease. The most advanced drug candidate AX200 has already entered phase ...

Anida Pharma, Inc.

Anida is a biopharmaceutical company developing novel first-in-class therapies to treat Parkinson’s disease, amyotrophic lateral sclerosis (ALS; Lou Gehrig disease), other central nervous system disorders, and hearing loss. Our therapeutic concept is based on activating the body’s own homeostatic mechanisms to regulate inflammation, prevent ...

Maas Biolab LLC

Maas Biolab is a private pharmaceutical company in Albuquerque, N.M., USA, developing Mitogard®, the only cyclosporine formula designed for CSF delivery, to treat amyotrophic lateral sclerosis. Maas Biolab holds FDA Orphan Drug Designation for cyclosporine to treat ALS and world patents for cyclosporine neuroprotection against chronic neurological disea...

Neurome, Inc

Neurome, Inc. is a discovery stage biotechnology company that seeks therapeutic solutions to human neurodegenerative diseases. The company focuses its efforts on Alzheimer's disease, Parkinson's disease, Huntington's disease, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) - usually fatal neurodegenerative disorders that are currently untreatable and share characteristics which mak...

Phase 2 Discovery, Inc.

Phase 2 Discovery (P2D) is a pharmaceutical company focused on developing innovative drugs that fulfill unmet medical needs in the treatment of central nervous system (CNS) disorders such as insomnia, anxiety, depression, attention disorders and neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS).At P2D, we are using our understanding of the treatme...

Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases. Neuraltus has three clinical-stage programs in its development pipeline, including potential treatments for Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's...

Amylyx Pharmaceuticals

Amylyx is developing a novel therapeutic for Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases that targets the neuroinflammation and nerve cell death that characterize these disorders. The company’s therapeutic, AMX0035, is a proprietary combination of existing compounds that Amylyx has shown have synergistic effects in prevent...

PharMetrics, Inc.

PharMetrics, Inc. is a leading provider of healthcare market insights to the pharmaceutical, biotech, medical device, and health plan sectors of the market. All of our market insights are provided by virtue of our unique longitudinal database of patient-level information. PharMetrics strictly adheres to the requirements of the Health Insurance Portability and Accountability Act (HIPAA).

Premier Biomedical Inc.

Premier Biomedical, Inc. is a research-based company that intends to discover and develop medical treatments for humans, in collaboration with the University of Texas at El Paso and US Department of Defense, specifically targeting the treatment of Alzheimer's disease, Fibromyalgia, Multiple Sclerosis, Traumatic Brain Injury, Amyotrophic Lateral Sclerosis (...

Bactevo

Bactevo has built a unique and game-changing Totally Integrated Medicines Engine (TIME) to create novel therapeutics. Utilising its paradigm shift in the speed, efficiency and quality of drug discovery, as well as massively enhancing safety profiling to improve clinical success, Bactevo is developing breakthrough medicines for the treatment of diseases tha...

AcuraStem

AcuraStem is a biotechnology company formed in 2016 to create an innovative precision medicine platform, iNeuroRX™, which leverages patient stem cells and advanced machine learning technology to discover drugs for neurodegenerative diseases. The platform has revealed a novel ALS target from Dr. Justin Ichida’s lab at USC. AcuraStem is led by an e...

Business Insights Ltd.

Business Insights appreciate the importance of accurate, up-to-date incisive market and company analysis and our aim therefore is to provide a single, off-the-shelf, objective source of data, analysis and market insight. Business Insights work in association with leading industry experts to produce a range of reports across a wide range of industry sectors. By working in association with so many e...

FaustPharmaceuticals

Created in October 2001, FaustPharmaceuticals is a spin-off of the Centre National de Recherche Scientifique (CNRS), based on technologies developed by Dr. Maurice Israel. In November 2003, FaustPharmaceuticals acquired Euroclide.Up to date, FaustPharmaceuticals has raised M€ 19 in two series of fund raising (M€ 3 in Feb. 2002, M€ 16 in Apr. 2004).After a first year of incubation in the labo...

SYGNIS Pharma AG

SYGNIS Pharma AG, headquartered in Heidelberg, is a specialty pharmaceutical company listed on the Prime Standard of the German stock exchange. The Company is focused on the research, development and marketing of innovative therapies for the treatment of disorders of the Central Nervous System. These include stroke, amyotrophic lateral sclerosis (ALS) and neurological disorders resulting from in...

Brainstorm Cell Therapeutics

BrainStorm (OTC BB: BCLI) is a company that is developing stem cell technologies to provide treatments for currently incurable neurodegenerative diseases. The Company is focused on developing adult stem cells taken from the patient's own bone marrow to treat diseases such as Parkinson's Disease (PD), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) and Multiple Sclerosis (MS). The adu...

California Stem Cell, Inc.

California Stem Cell, Inc. is a privately held company focused on the manufacture of high-purity human cells for therapeutic development and screening applications. Since its founding in 2005, CSC has developed and has intellectual property surrounding methods for scalable production of human motor neurons, neuronal progenitors, cardiac cells and liver cel...

Bactevo Ltd.

Bactevo has built a unique, game-changing Totally Integrated Medicines Engine (TIME) to create novel therapeutics. Enabled by advance machine learning, TIME utilises its paradigm shift in the speed, efficiency and quality of drug discovery, as well as dramatically enhanced safety profiling, to improve clinical success. In addition to working with partners ...

Yumanity Therapeutics

Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding. Formed in 2014 by renowned biotech industry leader, Tony Coles, M.D., and protein folding science pioneer, Susan Lindquist, Ph.D., the company is initially focused on discovering disease-modifying therapies for patients with Alzheimer’s di...

IDC Health Insights

IDC Health Insights provides health and life sciences industry executives, and the suppliers who serve them, with market research and advisory services. The company’s coverage spans the entire health industry value chain and closely follows the payer, provider and life sciences markets with special emphasis on developing and employing strategies that ...

Nanna Therapeutics

Nanna Therapeutics has built a unique, game-changing Totally Integrated Medicines Engine (TIME) to create novel therapeutics. Enabled by advanced machine learning, TIME utilises its paradigm shift in the speed, efficiency and quality of drug discovery, as well as dramatically enhanced safety profiling, to improve clinical success. In addition to working wi...


More From BioPortfolio on "Amyotrophic lateral sclerosis Market Insights Epidemiology Market Forecast"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks